In this webinar, our speakers Dr. Carme Font, Prof. Tzu-Fei Wang, and Prof. Marc Carrier talked about the recent updates on cancer and thrombosis in the COVID-19 era.
• An update on the EPIPHANY study on serious complications prediction in patients with cancer
• Drug-drug interaction in the real-world setting of thrombosis and cancer
• Thromboprophylaxis dosing in COVID-19 patients
Prof. Ingrid Pabinger-Fasching chaired this event.
The recording and slides are available for our community members.
Register to our community to access them.